BioCryst Pharmaceuticals, Inc.
MX ˙ BMV ˙ US09058V1035
SecurityMX:BCRX / BioCryst Pharmaceuticals, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership53,965 shares
Latest Disclosed Value $ 513,746
Simplex Trading, Llc ownership in BCRX / BioCryst Pharmaceuticals, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 53,965 shares of BioCryst Pharmaceuticals, Inc. (MX:BCRX) valued at $513,746 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 0 shares of BioCryst Pharmaceuticals, Inc..

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (BCRX) in the form of stock options. The firm currently holds call options representing 240,900 of underlying shares valued at $2,293,368 USD and put options representing 34,700 of underlying shares valued at $330,344 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BCRX / BioCryst Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 53,965 53,965 514 0.0003
2026-02-11 2025-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -40,602 -100.00 0 0.0000
2025-11-12 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 40,602 29,118 253.55 0 0.0002
2025-08-05 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 11,484 -21,665 -65.36 0 0.0001
2025-05-12 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 33,149 33,149 0 0.0002
2024-11-08 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -26,565 -100.00 0 0.0000
2024-07-25 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 26,565 9,470 55.40 0 0.0001
2024-04-25 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 17,095 17,095 0 0.0000
2024-02-02 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -8,064 -100.00 0 0.0000
2023-11-01 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 8,064 8,064 0 0.0000
2023-08-04 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -63,313 -100.00 0 0.0000
2023-04-27 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 63,313 23,231 57.96 1 0.0005
2023-02-02 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 40,082 40,082 0 0.0005
2022-11-04 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -87,260 -100.00 0 -100.00
2022-08-03 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 87,260 21,075 31.84 923 -14.22 0.0010
2022-05-02 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 66,185 61,765 1,397.40 1,076 1,663.93 0.0010
2022-02-23 2021-12-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 4,420 -47,315 -91.46 61 -92.75 0.0001
2022-02-04 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 51,735 0 841 0.0004
2021-10-28 2021-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 51,735 -1,274 -2.40 841 0.36 0.0008
2021-08-12 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 53,009 13,138 32.95 838 0.0008
2021-04-26 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 39,871 -210,641 -84.08 0 -100.00
2021-02-02 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 250,512 224,394 859.15 1,866 1,996.63 0.0024
2020-10-14 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 26,118 15,679 150.20 89 81.63 0.0001
2020-07-13 2020-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 10,439 10,439 -60.03 49 -44.94 0.0001
2020-04-28 2020-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -2,903 -100.00 0 -100.00
2020-02-05 2019-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 2,903 2,903 10 0.0000
2019-04-18 2019-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -3,682 -100.00 0 -100.00
2019-01-16 2018-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 3,682 -3,616 -49.55 29 -47.27 0.0001
2018-10-23 2018-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 7,298 7,298 98.21 55 89.66 0.0002
2017-10-25 2017-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -59,614 -100.00 0 -100.00
2017-07-12 2017-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 59,614 55,402 1,315.34 331 845.71 0.0144
2017-04-21 2017-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 4,212 -28,003 -86.93 35 -82.76 0.0015
2017-01-11 2016-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 32,215 4,486 16.18 203 66.39 0.0121
2016-10-07 2016-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 27,729 27,729 -13.93 122 -39.90 0.0083
2015-07-08 2015-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -399 -100.00 0 -100.00
2015-04-21 2015-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 399 253 173.29 3 50.00 0.0003
2015-03-04 2014-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 146 146 2 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 240,900 2,293 n/a n/a n/a
2026-02-11 2025-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 0 -100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 69,400 -49.05 1 -100.00 n/a n/a n/a
2025-08-05 2025-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 136,200 125.87 1 n/a n/a n/a
2025-05-12 2025-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 60,300 -32.40 0 n/a n/a n/a
2025-02-11 2024-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 89,200 -36.65 1 -100.00 n/a n/a n/a
2024-11-08 2024-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 140,800 -5.95 1 n/a n/a n/a
2024-07-25 2024-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 149,700 -34.31 1 -100.00 n/a n/a n/a
2024-04-25 2024-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 227,900 135.68 1 n/a n/a n/a
2024-02-02 2023-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 96,700 -18.05 1 n/a n/a n/a
2023-11-01 2023-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 118,000 -45.22 1 -100.00 n/a n/a n/a
2023-08-04 2023-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 215,400 42.46 2 0.00 n/a n/a n/a
2023-04-27 2023-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 151,200 -35.66 1 -50.00 n/a n/a n/a
2023-02-02 2022-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 235,000 -39.54 3 -99.96 n/a n/a n/a
2022-11-04 2022-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 388,700 66.54 4,897 98.34 n/a n/a n/a
2022-08-03 2022-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 233,400 -21.86 2,469 -49.16 n/a n/a n/a
2022-05-02 2022-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 298,700 62.87 4,856 91.18 n/a n/a n/a
2022-02-23 2021-12-31 13F/A BIOCRYST PHARMACEUTICALS CALL Call 183,400 -27.68 2,540 -38.44 n/a n/a n/a
2022-02-04 2021-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 253,600 4,126 n/a n/a n/a
2021-10-28 2021-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 253,600 4.88 4,126 7.95 n/a n/a n/a
2021-08-12 2021-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 241,800 6,605.49 3,822 n/a n/a n/a
2021-04-26 2021-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 3,606 552.08 0 -100.00 n/a n/a n/a
2021-02-02 2020-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 553 821.67 411 1,955.00 n/a n/a n/a
2020-10-14 2020-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 60 -78.02 20 -84.62 n/a n/a n/a
2020-07-13 2020-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 273 333.33 130 983.33 n/a n/a n/a
2020-04-29 2020-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 63 530.00 12 300.00 n/a n/a n/a
2020-02-05 2019-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 10 -88.10 3 -87.50 n/a n/a n/a
2019-10-15 2019-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 84 -27.59 24 -44.19 n/a n/a n/a
2019-07-26 2019-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 116 61.11 43 -25.86 n/a n/a n/a
2019-04-18 2019-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 72 260.00 58 262.50 n/a n/a n/a
2019-01-16 2018-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 20 -13.04 16 -5.88 n/a n/a n/a
2018-10-23 2018-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 23 35.29 17 88.89 n/a n/a n/a
2018-07-30 2018-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 17 750.00 9 -47.06 n/a n/a n/a
2018-04-26 2018-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 2 -99.10 0 -100.00 n/a n/a n/a
2018-01-10 2017-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 221 -63.11 7 -68.18 n/a n/a n/a
2017-10-25 2017-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 599 53.20 22 4.76 n/a n/a n/a
2017-07-12 2017-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 391 -47.73 21 -40.00 n/a n/a n/a
2017-04-21 2017-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 748 87.94 35 -41.67 n/a n/a n/a
2017-01-11 2016-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 398 234.45 60 1,400.00 n/a n/a n/a
2016-10-07 2016-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 119 17.82 4 -71.43 n/a n/a n/a
2016-07-18 2016-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 101 -13.68 14 366.67 n/a n/a n/a
2016-04-14 2016-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 117 74.63 3 50.00 n/a n/a n/a
2016-01-20 2015-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 67 -84.91 2 -96.61 n/a n/a n/a
2015-10-08 2015-09-30 13F BIOCRYST PHARMACEUTICALS CALL Call 444 788.00 59 436.36 n/a n/a n/a
2015-07-08 2015-06-30 13F BIOCRYST PHARMACEUTICALS CALL Call 50 -63.24 11 175.00 n/a n/a n/a
2015-04-21 2015-03-31 13F BIOCRYST PHARMACEUTICALS CALL Call 136 -39.01 4 -90.70 n/a n/a n/a
2015-03-04 2014-12-31 13F BIOCRYST PHARMACEUTICALS CALL Call 223 43 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 34,700 330 n/a n/a n/a
2026-02-11 2025-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 0 -100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 84,200 -21.16 1 n/a n/a n/a
2025-08-05 2025-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 106,800 28.67 1 n/a n/a n/a
2025-05-12 2025-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 83,000 -4.38 1 n/a n/a n/a
2025-02-11 2024-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 86,800 36.26 1 n/a n/a n/a
2024-11-08 2024-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 63,700 32.43 0 n/a n/a n/a
2024-07-25 2024-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 48,100 -10.43 0 n/a n/a n/a
2024-04-25 2024-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 53,700 397.22 0 n/a n/a n/a
2024-02-02 2023-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 10,800 -74.77 0 n/a n/a n/a
2023-11-01 2023-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 42,800 28.53 0 n/a n/a n/a
2023-08-04 2023-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 33,300 -70.16 0 n/a n/a n/a
2023-04-27 2023-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 111,600 27.25 1 -100.00 n/a n/a n/a
2023-02-02 2022-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 87,700 57.73 1 -99.86 n/a n/a n/a
2022-11-04 2022-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 55,600 -76.46 700 -71.98 n/a n/a n/a
2022-08-03 2022-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 236,200 305.15 2,498 163.78 n/a n/a n/a
2022-05-02 2022-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 58,300 -44.05 947 -34.37 n/a n/a n/a
2022-02-23 2021-12-31 13F/A BIOCRYST PHARMACEUTICALS PUT Put 104,200 -34.51 1,443 -44.24 n/a n/a n/a
2022-02-04 2021-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 159,100 2,588 n/a n/a n/a
2021-10-28 2021-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 159,100 9.42 2,588 12.62 n/a n/a n/a
2021-08-12 2021-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 145,400 8,407.90 2,298 n/a n/a n/a
2021-04-26 2021-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 1,709 -15.02 0 -100.00 n/a n/a n/a
2021-02-02 2020-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 2,011 280.15 1,498 727.62 n/a n/a n/a
2020-10-14 2020-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 529 2,419.05 181 1,710.00 n/a n/a n/a
2020-07-13 2020-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 21 40.00 10 233.33 n/a n/a n/a
2020-04-29 2020-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 15 -64.29 3 -78.57 n/a n/a n/a
2020-02-05 2019-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 42 200.00 14 250.00 n/a n/a n/a
2019-10-15 2019-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 14 -94.31 4 -95.70 n/a n/a n/a
2019-07-26 2019-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 246 846.15 93 342.86 n/a n/a n/a
2019-04-18 2019-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 26 44.44 21 50.00 n/a n/a n/a
2019-01-16 2018-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 18 -30.77 14 -33.33 n/a n/a n/a
2018-07-30 2018-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-04-26 2018-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 53 6 n/a n/a n/a
2018-01-10 2017-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-10-25 2017-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 371 -42.75 11 -87.50 n/a n/a n/a
2017-07-12 2017-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 648 752.63 88 2,833.33 n/a n/a n/a
2017-04-21 2017-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 76 -41.98 3 -90.00 n/a n/a n/a
2017-01-11 2016-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 131 147.17 30 1,400.00 n/a n/a n/a
2016-10-07 2016-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 53 2,550.00 2 100.00 n/a n/a n/a
2016-07-18 2016-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 2 -66.67 1 -66.67 n/a n/a n/a
2016-04-14 2016-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 6 -72.73 3 200.00 n/a n/a n/a
2016-01-20 2015-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 22 -52.17 1 -80.00 n/a n/a n/a
2015-10-08 2015-09-30 13F BIOCRYST PHARMACEUTICALS PUT Put 46 283.33 5 400.00 n/a n/a n/a
2015-07-08 2015-06-30 13F BIOCRYST PHARMACEUTICALS PUT Put 12 33.33 0 -100.00 n/a n/a n/a
2015-04-21 2015-03-31 13F BIOCRYST PHARMACEUTICALS PUT Put 9 -96.39 1 -93.33 n/a n/a n/a
2015-03-04 2014-12-31 13F BIOCRYST PHARMACEUTICALS PUT Put 249 15 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.